G1 therapy: the targeted effects of triracilib reduce the incidence of multiple adverse events associated with Trop2 ADC
G1 疗法：曲拉西利布的靶向效应降低了与 Trop2 ADC 相关的多种不良事件的发生率
G1 therapy: the targeted effects of triracilib reduce the incidence of multiple adverse events associated with Trop2 ADC
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.